Milestone Pharmaceuticals USA, Inc.

Class 041: Education services, namely, providing on-line publications, patient information, and educational material in the field of research and development relating to heart diseases, management of heart diseases, and patient burden; Publication and distribution of educational information accessible via an online subscription specifically related to cardiovascular disorders; Providing information in the field of education regarding cardiovascular disorders; Providing a website featuring resources, namely, non-downloadable publications in the field of cardiovascular disorder diagnosis and the impact of same; Providing on-line non-downloadable publications, namely, blogs, videos, audio recordings, and slide presentations featuring medical information and information on patient burden and quality of life for patients diagnosed with cardiovascular disorders; Class 044: Providing patient educational health information in the field of medical treatment; Providing an interactive website featuring educational information in the field of medical treatment; Providing medical treatment information to patients with heart conditions via an online website; Providing medical information in the field of heart disorders, diseases, treatment and management; Providing a website featuring information in the field of cardiovascular conditions and the management of cardiovascular conditions; Providing a resource website featuring information in the field of medical treatments, disease diagnosis and disease management for people living with cardiovascular conditions for the purpose of assisting patients in learning and sharing information regarding cardiovascular conditions, diagnosis, management and treatment of cardiovascular disorders, and the impact of cardiovascular disorders on quality of life; Providing information, advisory and consultancy services relating to medical treatment for patients with cardiovascular disorders; Education services, namely, providing information, advisory and consultancy services relating to longevity and quality of life being information pertaining to mental and physical health, meditation therapy and sleep for patients with cardiovascular disorders; Education services, namely, providing health information, advisory and consultancy services relating to physical longevity and health being quality of life information pertaining to diet, nutrition, exercise and fitness for patients with cardiovascular disorders;

Pharmaceutical preparations; medicated nasal spray preparations; nasal sprays for medical purposes; medicated nasal sprays containing L-type calcium channel blockers; pharmaceutical preparations, namely, intranasal spray for acute treatment and relief of cardiovascular and non-cardiovascular disorders; Medical devices and instruments in the nature of nasal spray delivery devices; medical devices for administering medicines in the nature of nasal spray delivery devices; medical devices for facilitating the intranasal application of pharmaceutical preparations for acute treatment and relief of cardiovascular and non-cardiovascular disorders

Class 035: Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of cardiovascular disorders; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of cardiovascular disorders; Class 042: Providing medical and scientific research information in the field of heart disease and clinical trials; providing medical and scientific research information in the field of cardiovascular disorders and clinical trials; pharmaceutical research services in the field of heart disease and cardiovascular system; pharmaceutical drug development services in the field of heart disease and cardiovascular system; pharmaceutical research and development in the field of heart disease and cardiovascular system; medical and scientific research, namely, conducting clinical trials for others in the field of heart disease and cardiovascular system; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Class 044: Providing a resource website featuring information in the field of the treatment of episodic cardiovascular conditions; providing a resource website featuring information for people living with atrial fibrillation/atrial flutter; providing a resource website featuring information for people living with myocardial ischemia including angina; providing a resource website featuring information for people living with supraventricular tachycardias including paroxysmal

Class 041: Providing a resource website featuring on-line non-downloadable publications, namely, information sheets, brochures, templates for social media graphics and social media posts, and testimonial and informational videos, all in the field paroxysmal supraventricular tachycardia (PSVT), episodic cardiovascular conditions, and tips on starting a conversation with a doctor; Class 044: Providing a resource website featuring information in the field of medical treatments, disease diagnosis and disease management for people living with supraventricular tachycardias including paroxysmal supraventricular tachycardia (PSVT); Providing a website featuring information in the field of the treatment of episodic cardiovascular conditions; Providing information in the field of the treatment of episodic cardiovascular conditions; all for the purpose of assisting users in learning and sharing information and fostering a better understanding of PSVT, the diagnosis, management and treatment of PSVT, and its impact on people's lives; Class 045: Providing a website via a global computer network featuring supportive personal stories on the subject of living with paroxysmal supraventricular tachycardia (PSVT) including the path to their diagnosis and management of paroxysmal supraventricular tachycardia (PSVT) for the purpose of assisting users in learning and sharing information and fostering a better understanding of PSVT, the diagnosis, management and treatment of PSVT, and its impact on people's lives

Cardiovascular treatment preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, intranasally administered medications, and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular pharmaceuticals; "PHARMACEUTICALS"